Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for SPRY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 236.98M
March 31, 2026 226.26M
December 31, 2025 213.39M
September 30, 2025 225.15M
June 30, 2025 121.15M
March 31, 2025 98.34M
December 31, 2024 94.36M
September 30, 2024 16.62M
June 30, 2024 6.725M
March 31, 2024 3.715M
December 31, 2023 2.428M
September 30, 2023 11.27M
June 30, 2023 10.20M
March 31, 2023 10.04M
Date Value
December 31, 2022 8.549M
September 30, 2022 3.99M
June 30, 2022 15.21M
March 31, 2022 19.24M
December 31, 2021 16.68M
September 30, 2021 20.43M
June 30, 2021 17.33M
March 31, 2021 13.65M
December 31, 2020 11.93M
September 30, 2020 10.59M
June 30, 2020
March 31, 2020
December 31, 2019 21.25M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
Passage Bio, Inc. 20.72M
Vertex Pharmaceuticals, Inc. 7.175B
Capricor Therapeutics, Inc. 122.52M
Kyntra Bio, Inc. 109.22M
Zentalis Pharmaceuticals, Inc. 71.68M

Total Liabilities (Quarterly) Related Metrics